Similar to our findings, the one study to measure serum PlGF and sFlt-1 during pregnancy did not link these markers to subsequent breast cancer risk [23], although the follow-up time was short (10 years after the index pregnancy) and case accrual was low since most women were still premenopausal. This evidence concerns the gene PGF and breast carcinoma.